SimPath has licensed a novel cloning system developed by the Department of Energy’s Oak Ridge National Laboratory that generates and assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels.
SimPath has licensed a novel cloning system developed by the Department of Energy’s Oak Ridge National Laboratory that generates and assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels.